Funding
PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects. We want to smooth your path to progress. We blend the right funding with the right advice and the right people to give your idea the best chance of success.
PACE upcoming funding round: 2025 Antibacterial Therapeutics
Our third funding round will open on 1 October 2025. Applications must be focussed on developing new antibacterial therapeutics targeting Gram-negative bacterial infections with the highest burden of AMR. Projects are expected to last for up to two years, with total funding of up to £6 million available across all funded projects.
Expressions of interest can be submitted from when the call opens on 1 October until it closes on 5 November. Full details of the call scope, eligibility and application process will be provided when the call opens.
Sign up to receive PACE news to be alerted when the 2025 Antibacterial Therapeutics call is open
2024 Diagnostic Innovations Funding Round (Closed)
Our second funding round (launched in September 2024) focused on early-stage diagnostic innovations with the potential to reduce inappropriate antibiotic prescriptions, provide faster results to guide antimicrobial use and clinical decisions and/or catalyse the move to personalised narrow-spectrum treatments.
Learn More
2023 Antibacterials Therapeutics Funding Round (Closed)
Our first funding round (launched in October 2023) focused on early stage, novel antibacterial therapeutics.
Learn More
